Dennie T. Frederick
机构: Massachusetts General Hospital
每年引用次数
引用次数
引用: 25,990
H-指数: 63
I10-指数 : 105
出版物: 184
Clinical Utility of a Blood-Based BRAFV600E Mutation Assay in Melanoma
David J. Panka , Elizabeth Buchbinder , Anita Giobbie-Hurder , Aislyn P. Schalck
Molecular Cancer Therapeutics 13 ( 12) 3210 -3218
18
2014
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
I. Tirosh , B. Izar , S. M. Prakadan , M. H. Wadsworth
Science 352 ( 6282) 189 -196
2016
314 Optimal sequencing schedules for combining BRAF inhibition with BCL-2 inhibition
A. Schalck , D.T. Frederick , M.R. Hammond , I. Ferreiro-Neira
European Journal of Cancer 50 102
2014
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses
Whitney Silkworth , Rumya Raghavan , Rumya Raghavan , S. Alireza Rabi
Science Translational Medicine 13 ( 581)
38
2021
Abstract A01: A comprehensive collection of patient derived xenografts of human melanoma with clinical, genomic, and biological characterization
Clemens Krepler , Katrin Sproesser , Marilda Beqiri , Min Xiao
Clinical Cancer Research 22
2016
Abstract PR06: A co-clinical assessment of patterns of BRAF inhibitor resistance
Lawrence N. Kwong , Genevieve Boland , Dennie T. Frederick , Timothy Helms
Clinical Cancer Research 21
2015
Plasma-derived extracellular vesicle analysis and deconvolution enable prediction and tracking of melanoma checkpoint blockade outcome.
Alvin Shi , Gyulnara G. Kasumova , William A. Michaud , Jessica Cintolo-Gonzalez
Science Advances 6 ( 46)
6
2020
Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade
Zachary A. Cooper , Vikram R. Juneja , Peter T. Sage , Dennie T. Frederick
Cancer immunology research 2 ( 7) 643 -654
182
2014
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
Douglas B. Johnson , Garrett M. Frampton , Matthew J. Rioth , Erik Yusko
Cancer immunology research 4 ( 11) 959 -967
259
2016
Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome
Nicholas F. Lawrence , Marc R. Hammond , Dennie T. Frederick , Yuhua Su
Journal of the American Academy of Dermatology 75 ( 3) 595 -602
12
2016
Targeting the MAGE A3 antigen in pancreatic cancer
Alexandria P. Cogdill , Dennie T. Frederick , Zachary A. Cooper , Haven R. Garber
Surgery 152 ( 3)
16
2012
Overexpression of Mcl-1 confers resistance to BRAFV600E inhibitors alone and in combination with MEK1/2 inhibitors in melanoma.
Neel M. Fofaria , Dennie T. Frederick , Ryan J. Sullivan , Keith T. Flaherty
Oncotarget 6 ( 38) 40535 -40556
31
2015
Fitness Landscape of Clonal Hematopoiesis Under Selective Pressure of Immune Checkpoint Blockade.
Peter G. Miller , Christopher J. Gibson , Arnav Mehta , Adam S. Sperling
JCO precision oncology 4 ( 4) 1027 -1033
2020
Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy.
Melvyn T. Chow , Aleksandra J. Ozga , Rachel L. Servis , Dennie T. Frederick
Immunity 50 ( 6) 1498
135
2019
SPANX Control of Lamin A/C Modulates Nuclear Architecture and Promotes Melanoma Growth.
Ikrame Lazar , Bertrand Fabre , Yongmei Feng , Ali Khateb
Molecular Cancer Research 18 ( 10) 1560 -1573
1
2020
Correlation between immune-related adverse events and outcomes in nivolumab/ipilimumab combination therapy for metastatic melanoma.
Tatyana Sharova , Genevieve Marie Boland , Daan Rauwerdink , Dennie T. Frederick
Journal of Clinical Oncology 38 58 -58
2020
Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Gretchen M. Alicea , Vito W. Rebecca , Aaron R. Goldman , Mitchell E. Fane
Cancer Discovery 10 ( 9) 1282 -1295
55
2020
ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma.
Rani Ojha , Nektaria M. Leli , Angelique Onorati , Shengfu Piao
Cancer Discovery 9 ( 3) 396 -415
26
2019
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
Cory M. Johannessen , Laura A. Johnson , Federica Piccioni , Aisha Townes
Nature 504 ( 7478) 138 -142
320
2013
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman , Teppei Morikawa , Kevin Shee , Michal Barzily-Rokni
Nature 487 ( 7408) 500 -504
1,829
2012